Related Experiment Videos
Oxidation of 2-deoxyglucose by human polymorphonuclear leukocytes
Inflammation
|September 1, 1980
Summary
Human polymorphonuclear leukocytes (PMNLs) metabolize 2-deoxyglucose to carbon dioxide, particularly when stimulated. This process, crucial for PMNL function, is impaired in chronic granulomatous disease.
Area of Science:
- Immunology
- Cellular Metabolism
Background:
- Human polymorphonuclear leukocytes (PMNLs) play a critical role in immune responses.
- Understanding PMNL metabolic pathways is essential for comprehending their function and dysfunction.
Purpose of the Study:
- To investigate the metabolic fate of 2-deoxyglucose in human PMNLs.
- To determine the pathways involved in 2-deoxyglucose metabolism and its regulation by stimuli.
Main Methods:
- Utilized radiolabeled [1-14C]2-deoxyglucose to trace metabolic activity in human PMNLs.
- Stimulated PMNLs with phorbol myristate acetate (PMA) and opsonized zymosan.
- Assessed 2-deoxyglucose oxidation and transport in normal and defective PMNLs (chronic granulomatous disease).
Main Results:
- PMNLs metabolize 2-deoxyglucose to 14CO2 upon stimulation with PMA or zymosan.
- 2-deoxyglucose oxidation is less efficient than glucose oxidation but occurs in normal PMNLs, not in chronic granulomatous disease cells.
- PMA-induced oxidation does not fully explain transport inhibition, and zymosan-induced transport increase does not significantly boost oxidation.
Conclusions:
- 2-deoxyglucose metabolism in PMNLs is primarily mediated by the hexose monophosphate shunt.
- This pathway's activity with 2-deoxyglucose is intermediate compared to glucose.
- Enzymes of the hexose monophosphate shunt show reduced efficiency with 2-deoxyglucose derivatives.